Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model - Weber, Tobias; Bötticher, Benedikt; Arndt, Michaela; Mier, Walter; Sauter, Max; Exner, Evelyn; Keller, Armin; Krämer, Susanne; Leotta, Karin; Wischnjow, Artjom; Jäger, Dirk; Haberkorn, Uwe; et al. (Cancer letters, 2016)
Gesehen am 10.01.2018